BCR and COVID-19: As an application use-case, we validated the findings of convergent antibody sequences across three COVID-19 diagnosed individuals identified by Robbiani et al.[55] in a larger dataset comprising BCR repertoire samples from 97 individuals diagnosed with COVID-19 and 99 healthy controls retrieved from the from the AIRR Data Commons [56] by querying the iReceptor Gateway [57].